Loading
NASDAQHealthcareMedical - Instruments & Supplies
Latest quote
$2.07
+$0.01 · +0.49%
Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement. Their product range additionally features oxygen concentrators and specialized bathing devices. Established in 2006, the company is headquartered in Changzhou, China, and operates as a subsidiary of Jolly Harmony Enterprises Limited.
Previous close
$2.07
+$0.01 · +0.49%
Regular session · ET · Market data may be delayed.
Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement. Their product range additionally features oxygen concentrators and specialized bathing devices. Established in 2006, the company is headquartered in Changzhou, China, and operates as a subsidiary of Jolly Harmony Enterprises Limited.
Day range
Current $2.07
52-week range
Current $2.07
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
51
Fair Value
Sentiment
52
Mixed
Risk
96
Extreme Risk
Momentum
17
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement. Their product range additionally features oxygen concentrators and specialized bathing devices. Established in 2006, the company is headquartered in Changzhou, China, and operates as a subsidiary of Jolly Harmony Enterprises Limited.
Day range
Current $2.07
52-week range
Current $2.07
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 20.69M USD | 23.5M USD | 19.82M USD | 19.19M USD | 20.76M USD |
| Cost of goods sold | 14.64M USD | 14M USD | 13.04M USD | 12.99M USD | 14.4M USD |
| Gross profit | 6.04M USD | 9.5M USD | 6.78M USD | 6.2M USD | 6.36M USD |
| Research and development | 1.56M USD | 1.5M USD | 1.54M USD | 1.89M USD | 1.57M USD |
| Selling, general, and administrative | 3.88M USD | 4.37M USD | 2.37M USD | 2.18M USD | 2.16M USD |
| Operating expenses | 5.44M USD | 5.86M USD | 3.92M USD | 4.07M USD | 3.73M USD |
| Interest income | 789.07K USD | 466.52K USD | 182.68K USD | 181.61K USD | — |
| Interest expense | — | — | — | — | 9.49K USD |
| Depreciation and amortization | 324.68K USD | 346.13K USD | 225.9K USD | 357.27K USD | 341.25K USD |
| Operating income | 608.18K USD | 3.64M USD | 2.87M USD | 2.13M USD | 2.63M USD |
| Net income | 1.19M USD | 3.68M USD | 2.88M USD | 2.71M USD | 2.63M USD |
Company facts updated Sep 13, 2026.
Recent quarterly results
Recent quarterly results
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Mar 16, 2026 | 1:20 | — | — |
Stock split | Feb 8, 2024 | 20:1 | — | — |
Effective Mar 16, 2026
1:20
Effective Feb 8, 2024
20:1
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
